Gracell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gracell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gracell Today - Breaking & Trending Today

Gracell Biotechnologies Announces Shareholders' Approval of

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ:. ....

United States , Cayman Islands , Companies Act As Revised Of The Cayman , Astrazeneca Treasury , Company American Depositary , Gracell Biotechnologies Inc , Astrazeneca Treasury Limited , Grey Wolf Merger Sub , Merger Agreement , Contingent Value Rights Agreement , Companies Act , Merger Sub , Ordinary Shares , American Depositary Shares , Nasdaq Global Select Market , Nasdaq Grcl , Gracell Biotechnologies Inc , Ar T , Cell Therapy , Hina Adr ,

AstraZeneca to buy Gracell Technologies for $1.2bn

AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn. ....

B1 2bn , Category All , Category Company News , Categorym A , Category Headline News , Category Fidelity Top Stories , Mostread Company News ,

Gracell Biotechnologies Initiates Investigational Study Evaluating GC012F for Treatment of Refractory Systemic Lupus Erythematosus

SAN DIEGO - Gracell Biotechnologies Inc. , a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer and. | May 16, 2023 ....

Marvin Tang , William Cao , Fierce Life Sciences Innovation , Exchange Commission , Gracell Biotechnologies Inc , Chief Executive Officer , Investigational New Drug , Biotech Innovation , Life Sciences Innovation Awards , Private Securities Litigation Reform Act , Risk Factor , News Publishing , Gracell Biotechnologies Inc Stock Exchange , Press Release , Ancer Grcl Us38406l1035 ,

Gracell Biotechnologies Initiates Investigational Study Evaluating GC012F for Treatment of Refractory Systemic Lupus Erythematosus (SLE)

Gracell announces start of investigator-initiated trial to expand clinical evaluation of FasTCAR-T GC012F into autoimmune disease
GC012F pioneers the use of CD19/BCMA dual-targeting CAR-T in SLE,. | May 15, 2023 ....

New York , United States , Marvin Tang , Jessica Laub , William Cao , Stephanie Carrington , Fierce Life Sciences Innovation , Exchange Commission , Gracell Biotechnologies Inc , Gracell Biotechnologies , Chief Executive Officer , Investigational New Drug , Biotech Innovation , Life Sciences Innovation Awards , Private Securities Litigation Reform Act , Rheumatic Diseases , Current Rheumatology Diagnosis , Gracell Biotechnologies Inc Stock Exchange , Press Release , N Grcl Us38406l1035 ,

Gracell Biotechnologies to Host KOL Webinar on Multiple Myeloma on May 22nd

SAN DIEGO and SUZHOU, China and SHANGHAI, China, May 15, 2023 Gracell Biotechnologies Inc. , a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and. | May 15, 2023 ....

Gracell Biotechnologie , Saadz Usmani , Gracell Biotechnologies Inc , Cellular Therapy Specialist , Myeloma Service , Memorial Sloan Kettering Cancer , Webcast Details , Video Webcast , Gracell Biotechnologies Inc Stock Exchange , Press Release , Fficacious Grcl Us38406l1035 ,